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Background.— Non-invasive methods allow the evaluation of structural and functional arterial
abnormalities. So far, no study has focused on the comparison of vascular parameters by type
of cardiovascular event.
Methods.— In this pilot study, cardiovascular risk factors, carotid parameters, carotid-to-
femoral pulse wave velocity (PWV), brachial ﬂow-mediated dilation and ambulatory blood
Abbreviations: ABPM, ambulatory blood pressure monitoring; ACS, acute coronary syndromes; CCA, common carotid artery; CSA, cross-
sectional area; CT, computed tomography; DBP, diastolic blood pressure; Dd, carotid diameter during diastole; Ds, carotid diameter during
systole; ECG, electrocardiogram; IAS, ischaemic atherothrombotic stroke; IMT, intima-media thickness; MRI, magnetic resonance imaging;
NASCET, North American Symptomatic Carotid Endarterectomy Trial; PWV, pulse wave velocity; S, standard systolic expansion; SBP, systolic
blood pressure; SD, standard deviation.
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pressure were assessed in patients who presented with acute coronary syndromes (ACS) or
ischaemic atherothrombotic stroke (IAS). Groups were matched for age and gender.
Results.— Prevalences of hypertension, diabetes and dyslipidaemia and heredity, smoking and
body mass index were similar in the ACS (n = 50) and IAS (n = 50) groups. Carotid intima-media
thickness (IMT) and PWV were signiﬁcantly higher in the IAS vs. ACS group (769± 180 vs.
701± 136m; P = 0.039 and 12.5± 3.5 vs. 10.7± 2.4m/s; P = 0.006). Carotid distensibility was
signiﬁcantly lower in the IAS vs. ACS group (16.2± 3.2 vs. 18.9± 7.6 10−3/kPa; P = 0.02). These
differences persisted after adjustment for blood pressure for carotid distensibility but not for
PWV. The prevalences of endothelial dysfunction and carotid plaques were not signiﬁcantly
different in the ACS and IAS groups (86% and 74%; 80% and 78%). In a multivariable model,
carotid distensibility remained associated with ACS (odds ratio 1.19; 95% conﬁdence interval
1.03—1.38; P = 0.016).
Conclusions.— Stiffness and carotid wall thickness were higher in IAS than in ACS patients. These
differences may support the interest in new therapeutic targets for cardiovascular secondary
prevention.
NCT No.— NCT00926874.
© 2014 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte.— Des méthodes non invasives permettent maintenant d’évaluer les anomalies struc-
turelles et fonctionnelles des artères. Aucune étude à ce jour n’a comparé ces anomalies selon
l’événement athérothrombotique aigu.
Méthodes.— Dans une étude pilote, les facteurs de risque cardiovasculaires, les paramètres
carotidiens, la vitesse de l’onde de pouls (VOP), la dilatation de l’artère humérale médiée par
le ﬂux et la pression artérielle (PA) ambulatoire ont été évaluées chez patients qui ont présenté
soit un syndrome coronarien aigu (SCA) ou un accident vasculaire cérébral (AVC) ischémique
athérothrombotique (AVC), appariés pour l’âge et le sexe.
Résultats.— La prévalence de l’hypertension artérielle, le diabète, la dyslipidémie, l’hérédité,
le tabagisme et l’indice de masse corporelle étaient similaires dans les SCA (n = 50) et AVC
(n = 50) groupes. L’épaisseur intima-média carotidienne (EIM) et la VOP étaient signiﬁcative-
ment plus élevée dans le groupe AVC vs SCA (769± 180 vs 701± 136m; p = 0,039 et 12,5± 3,5 vs
10,7± 2,4m/s ; p = 0,006). La distensibilité carotidienne (DC) était signiﬁcativement plus faible
dans le groupe AVC vs SCA (16,2± 3,2 vs 18,9± 7,6 10−3/kPa ; p = 0,02). Cette différence per-
sistait pour la DC après ajustement pour la PA moyenne, mais pas pour la VOP. Les prévalences
de la dysfonction endothéliale et des plaques carotidiennes n’étaient pas signiﬁcativement dif-
férent dans les SCA et AVC groupes (86 % vs 74 % et 80 % vs 78 %). En analyse multivariée, DC
restait associée à la survenue d’un SCA (rapport de cotes 1,19 ; 95 % intervalle de conﬁance
1,03—1,38 ; p = 0,016).
Conclusions.— Chez les patients victimes d’un AVC ischémique athérothrombotique, la rigidité
et l’épaisseur de la paroi carotidienne était plus élevé que chez les patients victime d’un SCA.
Ces différences peuvent indiquer l’intérêt potentiel de nouvelles cibles thérapeutiques dans la
prévention secondaire cardiovasculaire.
NCT no.— NCT00926874.
© 2014 Elsevier Masson SAS. Tous droits réservés.
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eackground
ascular, cerebral and cardiac events are major causes of
orbidity and mortality in industrialized countries. Whereas
cute coronary syndromes (ACS) are primarily due to coro-
ary atherothrombosis, most ischaemic strokes are caused
y carotid atherosclerosis and emboligenic cardiopathy.
any cardiovascular risk factors can promote the develop-
ent of atherosclerosis, and their distribution differs by
isease type. Thus, hypertension is more common in patients
ith stroke whereas smoking and dyslipidaemia are more
arked in patients with coronary disease [1,2].
s
r
aDuring the evolution of atherothrombotic disease, the
rteries undergo modiﬁcations in their structure and func-
ion. These modiﬁcations, which can be analysed using
on-invasive techniques, could play a part in the rupture of
he plaque, which is responsible for the acute cardiovascu-
ar event. Laurent et al. [3] demonstrated, in a longitudinal
tudy, that an increase in arterial stiffness was an indepen-
ent predictive factor for fatal stroke in 1715 patients with
ssential hypertension. To the best of our knowledge, no
tudy has yet analysed arterial damages after the occur-
ence of an acute vascular event, comparing ischaemic
therothrombotic stroke (IAS) with ACS. The main objective
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wArterial properties after acute cardiovascular events
of this study was to compare functional and structural arte-
rial properties in patients who experienced two different
consequences of a single disease (i.e. atherothrombosis):
IAS and ACS. The hypothesis was that patients in the two
groups differ in terms of arterial damage, with various car-
diovascular risk factors.
Methods
Design and participants
This was a pilot, comparative, single-centre study con-
ducted at Grenoble University Hospital. Male and female
patients aged 40—70 years (to avoid selection of a partic-
ular atherothrombotic proﬁle) who had presented with a
completed IAS or ACS were included. Patients in the two
groups were matched for age and gender. Inclusions were
performed with a prospective sample of ﬁve patients in the
same age range (± 5 years) and gender for each group. Age-
and gender-matched patients without a history of acute car-
diovascular events constituted a control group.
Exclusion criteria were:
• for patients in the ACS group: stroke within the previ-
ous 6months (to decrease the role of acute biological and
vascular modiﬁcations occurring at the initial phase of
these two atherothrombotic events) or coronary bypass
performed between the beginning of hospitalization for
ACS and inclusion;
• for patients in the IAS group: cardioembolic disease (diag-
nosis left to the assessment of the neurologist having
treated the stroke) or ACS within the previous 6months;
• for all the patients: haemodynamic instability, atrial ﬁbril-
lation or ﬂutter, frequent extrasystoles (> 10/minute) (to
obtain valid 24-hour ambulatory blood pressure blood
pressure monitoring [ABPM]) and reduced mobility pre-
venting the patient from maintaining a standing position.
When a patient was admitted in the emergency depart-
ment at the hospital, their personal and family history was
recorded, along with their cardiovascular risk factor pro-
ﬁle and concomitant treatment. All patients underwent a
physical examination at inclusion, including cardiovascular
and neurological examinations, weight, height, abdominal
circumference, systolic blood pressure (SBP) and diastolic
blood pressure (DBP), heart rate measurement in accor-
dance with European guidelines on treating hypertension
[4,5] and an electrocardiogram (ECG). At the time of the
vascular event, when the patient was admitted in the emer-
gency department at the hospital, all patients underwent a
fasting blood sample for the measurement of lipid param-
eters, creatinine, insulin (no patients were treated with
insulin) and glucose and, for those in the ACS group, an
echocardiogram. In the 48 hours after the acute event,
transthoracic and/or transoesophageal echocardiographies
were performed for the IAS group, and all patients provided
urine samples for the measurement of albuminuria over a
24-hour period. For both groups, a 24-hour ABPM (Space-
labs 90207®, Redmond, WA, USA) was performed after a
‘usual period’ of hypertension post-stroke (1week after the
acute event). The vascular examinations (carotid parame-
ters, pulse wave velocity and endothelial function) were
performed at 9± 2 days after acute events.
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Ethical approval was obtained from the local ethics com-
ittee and all patients gave their written informed consent.
he registration (ClinicalTrials.gov) trial number for this
tudy is NCT00926874.
iagnosis of IAS and ACS
diagnosis of IAS was made on the basis of patient interview
ata, physical examination and imaging tests (computed
omography [CT] scan and/or magnetic resonance imag-
ng [MRI]) in the absence of haemorrhage but with direct
igns of ischaemia. Conventional neurological tests (ultra-
ound of the supra-aortic arteries, ECG monitoring, cardiac
ltrasound) were used to identify an atherothrombotic
echanism. An atherothrombotic mechanism was deﬁned
y:
the presence of atherosclerotic thrombosis or stenosis
(≥ 50% diameter reduction deﬁned by the North Ameri-
can Symptomatic Carotid Endarterectomy Trial [NASCET]
method and spectral Doppler ultrasound [6] or < 50% but
with plaque ulceration deﬁned as an indentation, ﬁssure
or erosion on the luminal surface by long- and short-axis
B-mode images [7]) in the clinically relevant extracranial
or intracranial artery;
the absence of acute cerebral infarction in a vascular ter-
ritory other than the one of the stenosed or occluded
artery;
the absence of argument for another mechanism, par-
ticularly because of normal 48-hour ECG monitoring,
normal transthoracic and transoesophageal echocardiog-
raphy and absence of coagulopathy.
Patients with an arterial disease other than atherosclero-
is (i.e. arterial dissection, vasculitis, arterial spasm) were
xcluded, as were patients who presented a lacunar stroke.
hese criteria were inspired by the Causative Classiﬁcation
ystem, which is an evidence-based classiﬁcation algorithm
or acute ischaemic stroke [8].
An ACS with persistent ST-segment elevation was diag-
osed on the basis of patient interview data, ECG with signs
f acute myocardial ischaemia and coronary angiography.
valuation of the structural and functional
roperties of the carotid artery wall
he two carotid arteries were studied successively by
ltrasonography in mode B using a HP Sonos 2500® ultra-
onic scanner (Hewlett-Packard®, CA, USA), equipped with
7.5MHz sector probe. Carotid internal diameter was
easured in two-dimensional mode in diastole (mini-
um diameter) and systole (maximum diameter) at 20mm
pstream of a carotid bifurcation. The stiffness () index
as calculated for both common carotid arteries (CCAs). The
index was calculated using the formula:
index = ln (SBP/DBP) /S
here SBP and DBP were measured at the time of recor-
®ing by a Dinamap device (Critikon, FL, USA) and S was the
tandard systolic expansion:
= (Ds − Dd) /Dd
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here Ds was the carotid diameter during systole and Dd was
he carotid diameter during diastole. Carotid distensibility
as calculated at both CCAs using the formula:
Carotid distensibility
= 2 × ((D/Dd)) / (pulse pressure/10 × 1.33 × 100)
here D=Ds−Dd and pulse pressure was the pulse pres-
ure measured at the time of recording by the Dinamap®
evice. Longitudinal sections of both CCAs were acquired at
0mm and more upstream of the carotid bifurcation during
wo consecutive cardiac cycles. The images were processed
sing a programme for automatic analysis of ultrasound
mages (TIMC laboratory, Grenoble University Hospital) to
alculate the intima-media thickness (IMT) of the posterior
all and the luminal diameter of both carotid arteries. The
recision and repeatability of the technique has been pre-
iously reported [9]. Similarly, each artery was examined
n the proximal extracranial external and internal sections,
n transverse and longitudinal two-dimensional sections, to
etect atheromatous plaques. The maximum thickness and
eat of the thickest plaque were determined. Arterial geom-
try was studied using the cross-sectional area (CSA) deﬁned
y:
SA = × (IMTd + (Dd/2))2 − × (Dd/2)2
here IMTd was the IMT at the end of diastole. Arterial
ypertrophy was deﬁned as IMT≥ 800m in one of the two
CAs.
valuation of aortic stiffness
ortic stiffness was evaluated non-invasively by determin-
ng pulse wave velocity (PWV). This was measured by two
ensors placed simultaneously on the skin at the level of
he right common carotid and femoral arteries. Each sen-
or recorded the pressure wave in the subjacent artery. The
ime between the start of the carotid wave and that of
he corresponding femoral wave (carotid-to-femoral tran-
it time) was measured automatically (Complior®, Colson,
arges-les-Gonesse, France). Carotid-to-femoral PWV was
eﬁned as the ratio between the distances separating the
wo sensors (measured by a tape measure) over the carotid-
o-femoral transit time.
valuation of endothelial function
ndothelial function was evaluated non-invasively by a tran-
ient ischaemic test on the forearm. Blood pressure was
easured conventionally after 10minutes of rest, then
cuff was placed on the forearm homolateral to the
ested arm and inﬂated to a pressure 50mmHg more than
he patient’s SBP for 5minutes, then rapidly deﬂated. A
igh-resolution ultrasound probe (HP Sonos 2500® machine
quipped with a 7.5MHz emission frequency probe) was
ositioned to obtain a longitudinal section of the brachial
rtery. The luminal diameter of the brachial artery was mea-
ured in end diastole over ﬁve successive cardiac cycles,
t a basic level (T0) and during hyperaemia (60 seconds
fter complete deﬂation of the cuff [T60]). Data are given
s percentage variation between T60 and T0. An abnormal
t
b
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esponse (i.e. endothelial dysfunction) was deﬁned by a vari-
tion in diameter < 10%.
tatistical analysis
eing a pilot study, the calculation of the number of patients
n both groups could not be based on the data set. Taking
nto account the ability to enrol patients in our institution,
total of 100 patients (50 in each group) were included in
he study.
Continuous variables are expressed as mean± standard
eviation (SD). In the event of abnormal distribution, a
ariable transformation was carried out by calculating its
ogarithm and the variable was expressed as a median and
uartiles (25th, 75th). Qualitative variables were described
s frequencies and percentages. Continuous variables were
ompared among three groups using ANOVA if normally
istributed, else using Kruskall—Wallis test. Categorical
ariables as counts and percentages. Categorical varia-
les of patients in different groups were compared using
hi2 or exact test. Comparisons of data between the two
atient groups (IAS and ACS) were made for continuous
ariables using Student’s t-test for parametric series or a
ann—Whitney non-parametric test in the event of non-
ormal distribution; and for categorical variables using a
hi2 test.
We used logistic regression models to evaluate which
haracteristics, biological parameters or functional and
tructural arterial components were related to the vascu-
ar events (ACS compared with IAS). All of the variables
ssociated with ACS at univariate analysis with P < 0.15
ere initially included and removed in a backward stepwise
nalysis. The proportional odds assumption of the logistic
odel was assessed with the Hosmer—Lemeshow goodness-
f-ﬁt test. Multiple regression analysis was performed using
stepwise model to determine which variables predicted
rterial damage in each group. We used seemingly unrelated
egression to compare -coefﬁcients and interpret relations
etween arterial parameters and risk factors in each group.
or all statistical tests, P < 0.05 was used as the signiﬁcance
hreshold. Statistical analyses were performed using Stata
2.1 (Stata Corp LP, College Station, TX, USA) software.
esults
he characteristics of the ACS, IAS and control groups are
ummarized in Table 1. There were no signiﬁcant differ-
nces in general characteristics or treatments between the
CS and IAS groups, but all of the blood pressure param-
ters were signiﬁcantly higher in the IAS than the ACS
roup (clinic SBP: 140± 18 vs. 123± 18mmHg, P < 0.0001;
linic DBP: 82± 10 vs. 74± 10mmHg, P < 0.0001; clinic pulse
ressure: 58± 13 vs. 49± 13mmHg, P < 0.0001; 24-h SBP:
35± 17 vs. 113± 13mmHg, P < 0.0001; 24-h DBP: 81± 10
s. 70± 8mmHg, P < 0.0001; 24-h pulse pressure: 53± 12
s. 42± 9mmHg, P < 0.0001). Around half of the patients
ith IAS had poorly controlled hypertension 1week after
he event despite antihypertensive treatment (54% by clinic
lood pressure measurement and 49% by ABPM). The preva-
ence of non-dipper status and heart rate did not differ
etween the ACS and IAS groups. Participants in the control
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Table 1 Characteristics and prior treatments of the population at inclusion according to the vascular event.
ACS (n = 50) IAS (n = 50) Control (n = 120) P (between 3 groups) P (ACS vs. IAS)
Age (years) 55± 7 57± 8 57± 9 0.55 —
Men 86 86 86 0.93 —
Body mass index
(kg/m2)
27.8± 4.1 27.4± 4.9 26.2± 3.1 0.42 0.50
Abdominal
circumference (cm)
95.8± 14.0 97.0± 14.0 92.1± 10.9 0.12 0.65
Hypertension 34 40 8.3 ≤ 0.001 0.53
Active smoking 42 28 3.3 ≤ 0.001 0.14
Smoking (pack years) 24± 17 19± 17 7.4± 13 ≤ 0.001 0.13
Diabetes 12 14 2.5 ≤ 0.005 0.77
History of coronary
heart disease
26 16 — 0.32
History of IAS 0 6 — 0.24
Family history of IAS 14 24 6.7 ≤ 0.007 0.20
Family history of ACS 58 40 10 ≤ 0.001 0.07
Medical treatment before acute atherothrombotic event
Antihypertensive
drugs
44 40 — 0.84
Calcium channel
blocker
12 8 — 0.74
Beta-blocker 26 12 — 0.12
Diuretic 18 22 — 0.80
ARB 10 14 — 0.76
ACE inhibitor 24 18 — 0.62
Oral antidiabetic 6 8 — 0.69
Statin 34 16 — 0.06
Data are mean± standard deviation or %. ACE: angiotensin-converting enzyme; ACS: acute coronary syndromes; ARB: angiotensin II
herot
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Ireceptor blocker; DBP: diastolic blood pressure; IAS: ischaemic at
group had fewer cardiovascular risk factors than patients in
the ACS and IAS groups.
Biological parameters are summarized in Table 2. Triglyc-
eride levels, glycaemia and insulinaemia were higher in the
ACS than the IAS group, but the other parameters were not
different between the two groups. Participants in the con-
trol group had lower triglyceride, insulin and high-sensitivity
C-reactive protein (hs-CRP) but higher cholesterol and cre-
atinine levels than patients in the ACS and IAS groups.
Arterial structural and functional parameters are summa-
rized in Table 3. Carotid IMT and CSA and carotid-to-femoral
PWV were higher in the IAS than the ACS group, while carotid
distensibility was signiﬁcantly lower. After adjustment for
blood pressure, the differences between two groups were
no longer signiﬁcant for CSA (P = 0.70) and PWV (P = 0.46) but
persisted for carotid distensibility (P = 0.002). There were no
differences between the two groups in terms of wall hyper-
trophy, plaque at the carotid level or carotid -index. The
prevalence of endothelial dysfunction was similarly high in
both groups.
Table 4 shows results of the logistic regression anal-
ysis comparing ACS with IAS. Only carotid distensibility
a
l
b
rhrombotic stroke; SBP: systolic blood pressure.
nd metabolic disturbance remained signiﬁcant in the mul-
ivariable model. Table 5 shows the correlation levels
etween arterial damage and cardiovascular risk factors.
sing multiple regression analysis, the variables indepen-
ently associated with arterial damage differed by group.
owever, when we compared  coefﬁcients to interpret the
elationships between arterial parameters and cardiovascu-
ar risk factors, we failed to demonstrate a dominant role of
hese risk factors in development of functional or structural
lterations of large arteries.
iscussion
n our study, in groups matched for age and gender, the
unctional and structural properties of arteries were dif-
erent in patients who presented an IAS or ACS—carotid
MT was larger, carotid eccentric hypertrophy more common
nd carotid distensibility lower in the IAS group. Endothe-
ial dysfunction and carotid atherosclerosis were similar in
oth groups. After multivariable analysis, carotid stiffness
emained inversely associated with IAS.
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Table 2 Biological parameters at inclusion according to the vascular event.
ACS (n = 50) IAS (n = 50) Control (n = 120) P (between 3
groups)
P (ACS vs. IAS)
Triglycerides (mmol/L) 1.56 (1.08—2.10) 1.20 (0.87—1.63) 1.04 (0.82—1.38) ≤ 0.001 0.016
Total cholesterol (mmol/L) 5.08± 1.39 5.15± 1.03 5.50± 0.91 ≤ 0.01 0.37
HDL cholesterol (mmol/L) 1.28± 0.41 1.42± 0.39 1.56± 0.39 ≤ 0.001 0.08
LDL cholesterol (mmol/L) 2.99± 1.11 3.13± 0.81 3.97± 0.87 0.21 0.19
Serum creatinine (mol/L) 83.0± 25.4 83.4± 16.8 92.0± 15.0 ≤ 0.001 0.43
Serum glucose (mmol/L) 5.89± 2.16 4.92± 0.74 5.17± 1.08 ≤ 0.018 < 0.01
UEA (mg/L) 16.6± 13.7 17.5± 12.1 — — 0.58
Serum insulin (UI/mL) 7.88 (5.98—10.69) 6.41 (3.86—9.15) 5.17 (4.19—8.01) ≤ 0.013 0.04
hs-CRP (mg/L) 8.0 (4.6—15.4) 4.9 (2.1—12.4) 1.3 (0.6—2.2) ≤ 0.001 < 0.07
Data are mean± standard deviation or median (interquartile range). ACS: acute coronary syndromes; IAS: ischaemic atherothrombotic
stroke; HDL: high-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein; LDL: low-density lipoprotein; UEA: urine excretion of
g
r
o
p
a
A
p
talbumin.
Carotid remodelling was different between the two
roups. The IAS group showed eccentric hypertrophic
emodelling more frequently than the ACS group. This type
f remodelling is more commonly found in hypertensive
atients [10—12]. The relationship between hypertension
nd increased IMT has been well described [13—15].
u
a
b
Table 3 Functional and structural arterial components at inc
ACS (n = 50) IAS (n = 50)
Carotid arteries
IMT (m) 701± 136 769± 180
Lumen
diameter (m)
6274± 845 6443± 705
CSA (mm2) 14.9 (12.6—17.5) 16.4 (14.4—20.0)
Wall
hypertrophy
38 52
Atheromatous
plaque
80 78
-index 8.8 (7.1—10.5) 8.3 (7.1—11.8)
Carotid
distensibility
(10−3/kPa)
18.9± 7.6 16.2± 3.2
Carotid-to-
femoral PWV
(m/s)
10.7± 2.4 12.5± 3.5
Endothelial
function:
T60—T0 (%)
6.2 (2.8—9.0) 5.5 (2.9—0.7)
Endothelial
dysfunctiona
86 74
Data are mean± standard deviation, median (interquartile range) or %
ischaemic atherothrombotic stroke; IMT: intima-media thickness; PWV:
a Variation in diameter T60—T0 < 10%.lthough we did not ﬁnd any signiﬁcant difference in the
revalence of carotid atherosclerotic plaque between the
wo groups, this was high, conﬁrming the interest in eval-
ating carotid atheroma as an indicator of the extent of
therosclerotic lesions, both at the coronary and cere-
rovascular level [16,17].
lusion according to the vascular event.
Control (n = 120) P (overall) P (ACS vs. IAS)
704 (604—791) ≤ 0.046 0.039
6209± 598 ≤ 0.029 < 0.28
14.4 (12.6—17.4) ≤ 0.01 0.036
— — 0.12
25 ≤ 0.001 0.81
7.9 (6.5—10.6) ≤ 0.46 0.78
23.6± 9.1 ≤ 0.001 0.02
10.1± 2.0 ≤ 0.001 0.006
— — 0.90
— — 0.54
. ACS: acute coronary syndromes; CSA: cross-sectional area; IAS:
pulse wave velocity.
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Table 4 Logistic regression analyses to compare ACS and IAS.
ACS (n = 50) vs. IAS (n = 50) Univariate analysis Multivariable analysis
OR (95% CI) P OR (95% CI) P
Carotid distensibility 1.15 (1.02—1.29) 0.023 1.19 (1.03—1.38) 0.016
Carotid IMT 0.99 (0.994—0.999) 0.046 0.997 (0.994—1.001) 0.14
Serum insulin 1.11 (0.998—1.23) 0.054 1.15 (1.01—1.30) 0.029
Serum glucose 1.78 (1.14—2.80) 0.012 1.90 (1.09—3.30) 0.023
Triglycerides 1.80 (1.05—3.10) 0.033 — —
Family history of ACS 2.07 (0.93—4.60) 0.073 — —
PWV 0.82 (0.71—0.95) 0.009 — —
HDL cholesterol 0.41 (0.15—1.13) 0.086 — —
ACS: acute coronary syndromes; IAS: ischaemic atherothrombotic stroke; CI: conﬁdence interval; HDL: high-density lipoprotein; IMT:
intima-media thickness; OR: odds ratio; PWV: pulse wave velocity.
t
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[
dOur results revealed differences in the functional proper-
ties of the carotid arteries according to the vascular event,
with carotid distensibility being lower in the IAS group,
attesting to greater arterial stiffness. This observation sup-
ports the potential interest in new therapeutic targets in
the secondary prevention of cardiovascular events. This
was the idea behind the development of advanced glyca-
tion end-product cross-link breakers, molecules that have
demonstrated their ability to reduce arterial stiffness in
hypertensive patients [18], but were eventually shown to
be toxic.
i
p
t
i
Table 5 Multiple regression analyses evaluating different art
groups.
Multiple regression parameters ACS (n = 50)
 Pa
Carotid IMT
Agec 0.308 0.056
24-hour SBPc 0.258 0.13
Smokingd 0.286 0.027
PWV
Agec 0.474 ≤ 0.001
24-hour SBPc 0.441 0.002
Carotid distensibility
Clinic SBP −0.501 0.010
Carotid CSA
Agec 0.377 0.004
24-hour SBPc 0.353 0.017
Smokingd 0.374 ≤ 0.001
ACS: acute coronary syndromes; IAS: ischaemic atherothrombotic strok
pulse wave velocity; SBP: systolic blood pressure.
a Linear regression model.
b Seemingly unrelated estimation.
c Analysed as a continuous variable.
d Pack years.In our study, the impact of each cardiovascular risk fac-
or on the occurrence of vascular remodelling seems not
o differ by event type. For secondary cardiovascular pre-
ention, all cardiovascular risk factors must be considered.
owever, in accordance with a previous study of our group
19], we showed a signiﬁcant association between metabolic
isturbances and ACS. Treatment of arterial stiffening and
nsulin resistance could be new strategies for the secondary
revention of IAS and ACS, respectively. The interest of
hese strategies can only be assessed by prospective stud-
es. In our study, several parameters were not signiﬁcantly
erial damage as dependent variables for the ACS and IAS
IAS (n = 50) Group comparison
 Pa Pb
0.399 0.016 0.66
0.505 0.002 0.26
0.349 0.027 0.78
0.574 0.002 0.66
0.463 0.003 0.91
−0.300 ≤ 0.001 0.41
0.363 0.015 0.95
0.538 ≤ 0.001 0.33
0.357 0.07 0.94
e; CSA: cross-sectional area; IMT: intima-media thickness; PWV:
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[50
ifferent between the two groups. For example, the carotid
-index, an index of arterial stiffness, was similar in both
roups. This could be explained by the lack of difference
etween the two groups with respect to the prevalence of
arotid plaques. Indeed, some authors have reported the
ajor role of plaque in the intensity of vascular stiffness
20]. Despite the availability of many tools for evaluating
arotid stiffness, longitudinal studies of cardiovascular mor-
idity and mortality are still negative with respect to these
arameters [21—23], except in those suffering from chronic
idney disease [24], where the speciﬁc role of highly calci-
ed atherosclerotic lesions has been noted [25].
Although PWV is a signiﬁcant and independent predictor
f cardiovascular mortality [21,26—29], after adjustment for
lood pressure, we found no signiﬁcant difference between
he two groups. However, it is difﬁcult to know whether
he abnormalities found are a cause or a consequence of
he ischaemic phenomenon. This is particularly true for
rterial properties correlated to blood pressure. Indeed,
fter adjustment for blood pressure, the differences in
SA and PWV between two groups were no longer signif-
cant. However, blood pressure data must be interpreted
ith caution since hypertension is common and reactive fol-
owing an ischaemic stroke. In our study, blood pressure
arameters were collected after haemodynamic stabiliza-
ion, as they were recorded 1week after the acute event.
n both the IAS and ACS groups, there was a strong alter-
tion in endothelium-dependent vasodilatation, recognized
s being linked to cardiovascular events [30]. Some authors
ave shown a relationship between the level of systemic
nﬂammation, the prevalence of atherosclerotic plaque and
ndothelial dysfunction [31]. In our study, all of these
arameters were abnormal in both groups in a similar man-
er.
Our study has various limitations. Our patients were stud-
ed just after a serious vascular event and, for ethical
easons, it was impossible to stop vasoactive treatment in
rder to analyse the vascular parameters. Also, our patients
ere relatively young, probably because they were receiv-
ng thrombolytic therapy in the stroke unit. Pairing the
atients and difference in treatments between the two
roups may have biased the results. However, the fact
hat vascular examinations took place on average 1week
fter the event reduces the likelihood of such rapid action
f the various treatments on arterial parameters, such as
arotid IMT and plaque. We used a non-stereotactic arm to
old the probe during evaluation of endothelial function.
espite these limitations, our study has several strengths.
irst, it was a comparative study (ACS vs. IAS). Second,
nly IAS and not cardioembolic or lacunar stroke patients
ere included, permitting the comparison of arterial alter-
tions in a single disease —atherosclerosis —but with two
ifferent atherothrombotic complications. Finally, vascular
henotyping was completed, both structural and functional.
onclusionsrterial damage varied depending on the vascular event of
therothrombotic disease. In patients with IAS, stiffness and
arotid wall thickness were higher than in patients with an
CS. These differences may support the potential interestG. Barone-Rochette et al.
n new therapeutic targets in the secondary prevention of
ardiovascular diseases.
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